Ticagrelor (TCG) is a P2Y12 platelet inhibitor and has
several crystal forms including Form II and Form V. In this work,
it has been confirmed that Form II TCG would gradually transform to
Form V in selected solvents. According to the crystal form stability,
a dynamic method was adopted to measure the solubility of Form II
TCG in six pure solvents (n-propanol, isopropanol, n-butanol, 2-butanol, ethyl acetate, and isopropyl acetate).
The solubility of Form V TCG in 12 pure solvents (methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-butanol,
methyl acetate, ethyl acetate, isopropyl acetate, acetone, 2-butanone,
and cyclohexanone) was measured by a static method. The solubility
measurement temperature range was from 273.15 to 313.15 K. The experimental
solubility data were correlated by the modified Apelblat model and
the λh model. It was shown that the calculated
solubility was consistent with the experimental data.